There is no product in the shopping cart, buy it!
| Size | Qty | Add To Basket |
|---|---|---|
| 1 mg | ||
| 500 μg |
| Product Overview | Recombinant human B2M protein (NP_004039.1) is produced in Glycoengineered Pichia pastoris. This expression system is used for the production of glycoproteins and antibodies with human post-translational modifications. |
| Source | Glycoengineered Pichia pastoris |
| Species | Human |
| Tag | His-tag, FC-tag |
| Purity | >90%, determined by SDS-PAGE. |
| Endotoxin Level | Regular batch |
| Conjugation | None |
| Target | B2M |
| Full Name | Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3] |
| Gene ID | 567 |
| Uniprot ID | P61769 |
| Accession Number | NP_004039.1 |
| Background | This gene encodes a serum protein found in association with the major histocompatibility complex (MHC) class I heavy chain on the surface of nearly all nucleated cells. The protein has a predominantly beta-pleated sheet structure that can form amyloid fibrils in some pathological conditions. The encoded antimicrobial protein displays antibacterial activity in amniotic fluid. A mutation in this gene has been shown to result in hypercatabolic hypoproteinemia. |
| Alternate Names | B2M; CDABP0092; HDCMA22P |